Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 12 results

Author Title [ Type

] Year

Filters: Author is Bird, AC [Clear All Filters]

Journal Article

Mathew, R., Sivaprasad, S., Florea, D., Leung, I., Sallo, F., Clemons, T., et al.. (2013). Agreement Between Time-Domain and Spectral-Domain Optical Coherence Tomography in the Assessment of Macular Thickness in Patients with Idiopathic Macular Telangiectasia Type 2. Ophthalmologica, 230, 144-150. presented at the 08/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23989133

Balaskas, K., Leung, I., Sallo, F., Clemons, T., Bird, A. C., & Peto, T.. (2014). Associations Between Autofluorescence Abnormalities and Visual Acuity in Idiopathic Macular Telangiectasia Type 2: MacTel Project Report Number 5. Retina, 34, 1630-1636. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24743635

Clemons, T. E., Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Figueroa, M. J., et al.. (2010). Baseline Characteristics of Participants in the Natural History Study of Macular Telangiectasia (MacTel) MacTel Project Report No. 2. Ophthalmic Epidemiol, 17, 66-73. presented at the 02/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=20100102

Chew, E. Y., Clemons, T. E., Peto, T., Sallo, F. B., Ingerman, A., Tao, W., et al.. (2015). Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial. Am J Ophthalmol, 159, 659-666.e1. presented at the 04/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25528956

Sallo, F. B., Peto, T., Egan, C., Wolf-Schnurrbusch, U. E., Clemons, T. E., Gillies, M. C., et al.. (2012). "En Face" OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia. Invest Ophthalmol Vis Sci, 53, 6145-6152. presented at the 09/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22899757

Parmalee, N. L., Schubert, C., Figueroa, M., Bird, A. C., Peto, T., Gillies, M. C., et al.. (2012). Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2. PLoS One, 7, e24268. presented at the 08/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22952568

Sallo, F. B., Peto, T., Egan, C., Wolf-Schnurrbusch, U. E., Clemons, T. E., Gillies, M. C., et al.. (2012). The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia. Invest Ophthalmol Vis Sci, 53, 7889-7895. presented at the 11/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23092925

Clemons, T. E., Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Wang, J. J., et al.. (2013). Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3. Ophthalmic Epidemiol, 20, 109-113. presented at the 04/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23510315

Sallo, F. B., Leung, I., Clemons, T. E., Peto, T., Bird, A. C., & Pauleikhoff, D.. (2015). Multimodal Imaging in Type 2 Idiopathic Macular Telangiectasia. Retina, 35, 742-749. presented at the 04/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25412037

Clemons, T. E., Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Figueroa, M., & Harrington, M. W.. (2008). The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project. Invest Ophthalmol Vis Sci, 49, 4340-4346. presented at the 10/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18586874

Heeren, T. F., Clemons, T., Scholl, H. P., Bird, A. C., Holz, F. G., & P Issa, C.. (2015). Progression of Vision Loss in Macular Telangiectasia Type 2. Invest Ophthalmol Vis Sci, 56, 3905-3912. presented at the 06/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26070062

Sallo, F. B., Leung, I., Chung, M., Wolf-Schnurrbusch, U. E., Dubra, A., Williams, D. R., et al.. (2011). Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia. Opthalmology, 118, 2461-2467. presented at the 12/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21839520